KURA — Kura Oncology Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapMomentum Trap

Annual balance sheet for Kura Oncology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	237	633	518	438	424
Net Total Receivables	0.03	—	—	—	—
Prepaid Expenses
Total Current Assets	240	637	522	446	432
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.278	8.36	8.25	6.38	8.85
Other Long Term Assets
Total Assets	242	647	534	456	449
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	15.6	26	22.5	24.1	35.3
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	23.2	36.3	27.4	36	51.7
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	219	611	507	420	397
Total Liabilities & Shareholders' Equity	242	647	534	456	449
Total Common Shares Outstanding